|
Basic Characteristics of Mutations
|
|
Mutation Site
|
G140S |
|
Mutation Site Sentence
|
In November 2014, a PhenoSense Integrase GT assay detected DRMs to NRTI, NNRTI, PI, and the INSTI-associated mutations E138T, G140S, and Q148H. |
|
Mutation Level
|
Amino acid level |
|
Mutation Type
|
Nonsynonymous substitution |
|
Gene/Protein/Region
|
IN |
|
Standardized Encoding Gene
|
gag-pol:155348
|
|
Genotype/Subtype
|
HIV-1 B |
|
Viral Reference
|
-
|
|
Functional Impact and Mechanisms
|
|
Disease
|
HIV Infections
|
|
Immune
|
- |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
- |
|
Treatment
|
INSTIs |
|
Location
|
- |
|
Literature Information
|
|
PMID
|
30568974
|
|
Title
|
Rapid Development of High-Level Resistance to Dolutegravir With Emergence of T97A Mutation in 2 Treatment-Experienced Individuals With Baseline Partial Sensitivity to Dolutegravir
|
|
Author
|
George JM,Kuriakose SS,Dee N,Stoll P,Lalani T,Dewar R,Khan MA,Rehman MT,Grossman Z,Maldarelli F,Pau AK
|
|
Journal
|
Open forum infectious diseases
|
|
Journal Info
|
2018 Sep 8;5(10):ofy221
|
|
Abstract
|
HIV integrase mutation T97A emerges after suboptimal therapy with integrase strand transfer inhibitors (INSTIs), but the contribution of T97A to dolutegravir resistance remains uncertain. Here we report >10-fold increase in dolutegravir resistance after the single addition of T97A in 2 individuals with prior INSTI resistance receiving dolutegravir salvage therapy.
|
|
Sequence Data
|
MH785272;MH785273
|